Abera Bioscience AB
556909-0904ActiveDeveloping next-generation nasal vaccines using modular OMV platform technology.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2012
- Founded
Key Decision Makers
Maria Alriksson
CEO
Mats Lundgren
CSO
Anders Ericsson
Executive Chairman of the Board
Joen Luirink
CTO, Co-Founder
+3 more contacts in Funnelfeedr
Description
Abera Bioscience AB is a Swedish biotechnology company specializing in the development of next-generation vaccines. They utilize a proprietary, modular Outer Membrane Vesicle (OMV) platform technology. This platform allows for rapid design and cost-effective production of vaccines that induce robust...
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556909090401
Decision Makers
7 contacts in FunnelfeedrMaria Alriksson
CEO
Mats Lundgren
CSO
Anders Ericsson
Executive Chairman of the Board
Joen Luirink
CTO, Co-Founder
Cristina Glad
Member of the Board
Fredrik Juserius
Member of the board
Harry Råstedt
Member of the board
Similar Companies
20 similar companies in FunnelfeedrNOVAVAX, INC.
Developing innovative protein-based vaccines using proprietary adjuvant technology.
Modus Therapeutics Holding AB
1–4 employeesSwedish biotech developing sevuparin for severe inflammatory conditions.
Novavax AB
100–199 employeesInnovating vaccines using proprietary technology platform and strategic partnerships.
SVANOVA AB
Developing innovative veterinary diagnostic solutions for animal health.
APTAMEDICA AB
Provides a real-time drug diagnostics platform for precision medicine.
Abera Bioscience AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo